Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.580
+0.290 (12.66%)
At close: Feb 5, 2026, 4:00 PM EST
2.599
+0.019 (0.74%)
After-hours: Feb 5, 2026, 7:59 PM EST
Opus Genetics Employees
Opus Genetics had 18 employees as of December 31, 2024. The number of employees increased by 4 or 28.57% compared to the previous year.
Employees
18
Change (1Y)
4
Growth (1Y)
28.57%
Revenue / Employee
$812,944
Profits / Employee
-$3,789,056
Market Cap
177.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| ProQR Therapeutics | 166 |
| Zentalis Pharmaceuticals | 166 |
| Molecular Partners AG | 153 |
| Century Therapeutics | 150 |
| Prelude Therapeutics | 131 |
| Nkarta | 105 |
| Compugen | 74 |
IRD News
- 3 days ago - Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026 - GlobeNewsWire
- 9 days ago - Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa - GlobeNewsWire
- 21 days ago - Opus Genetics, Inc. (IRD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts - GlobeNewsWire
- 7 weeks ago - Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 2 months ago - Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease - GlobeNewsWire
- 2 months ago - Opus Genetics to Participate in Upcoming Investment Conferences - GlobeNewsWire